BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22433061)

  • 1. Clinical features and outcome of X-linked lymphoproliferative syndrome type 1 (SAP deficiency) in Japan identified by the combination of flow cytometric assay and genetic analysis.
    Kanegane H; Yang X; Zhao M; Yamato K; Inoue M; Hamamoto K; Kobayashi C; Hosono A; Ito Y; Nakazawa Y; Terui K; Kogawa K; Ishii E; Sumazaki R; Miyawaki T
    Pediatr Allergy Immunol; 2012 Aug; 23(5):488-93. PubMed ID: 22433061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
    Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
    Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.
    Xu T; Zhao Q; Li W; Chen X; Xue X; Chen Z; Du X; Bai X; Zhao Q; Zhou L; Tang X; Yang X; Kanegane H; Zhao X
    Eur J Pediatr; 2020 Feb; 179(2):327-338. PubMed ID: 31754776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection.
    Shinozaki K; Kanegane H; Matsukura H; Sumazaki R; Tsuchida M; Makita M; Kimoto Y; Kanai R; Tsumura K; Kondoh T; Moriuchi H; Miyawaki T
    Int Immunol; 2002 Oct; 14(10):1215-23. PubMed ID: 12356686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency.
    Marsh RA; Bleesing JJ; Filipovich AH
    J Immunol Methods; 2010 Oct; 362(1-2):1-9. PubMed ID: 20816973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature.
    Lankester AC; Visser LF; Hartwig NG; Bredius RG; Gaspar HB; van der Burg M; van Tol MJ; Gross TG; Egeler RM
    Bone Marrow Transplant; 2005 Jul; 36(2):99-105. PubMed ID: 15908972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).
    Pachlopnik Schmid J; Canioni D; Moshous D; Touzot F; Mahlaoui N; Hauck F; Kanegane H; Lopez-Granados E; Mejstrikova E; Pellier I; Galicier L; Galambrun C; Barlogis V; Bordigoni P; Fourmaintraux A; Hamidou M; Dabadie A; Le Deist F; Haerynck F; Ouachée-Chardin M; Rohrlich P; Stephan JL; Lenoir C; Rigaud S; Lambert N; Milili M; Schiff C; Chapel H; Picard C; de Saint Basile G; Blanche S; Fischer A; Latour S
    Blood; 2011 Feb; 117(5):1522-9. PubMed ID: 21119115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members.
    Tabata Y; Villanueva J; Lee SM; Zhang K; Kanegane H; Miyawaki T; Sumegi J; Filipovich AH
    Blood; 2005 Apr; 105(8):3066-71. PubMed ID: 15632210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical flow cytometric screening of SAP and XIAP expression accurately identifies patients with SH2D1A and XIAP/BIRC4 mutations.
    Gifford CE; Weingartner E; Villanueva J; Johnson J; Zhang K; Filipovich AH; Bleesing JJ; Marsh RA
    Cytometry B Clin Cytom; 2014 Jul; 86(4):263-71. PubMed ID: 24616127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin lesions in a boy with X-linked lymphoproliferative disorder: comparison of 5 SH2D1A deletion cases.
    Mejstríková E; Janda A; Hrusák O; Bucková H; Vlcková M; Hancárová M; Freiberger T; Ravcuková B; Vesely K; Fajkusová L; Kopecková L; Sumerauer D; Kabícková E; Sedivá A; Stary J; Sedlácek Z
    Pediatrics; 2012 Feb; 129(2):e523-8. PubMed ID: 22271700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature.
    Jin YY; Zhou W; Tian ZQ; Chen TX
    Hum Immunol; 2016 Aug; 77(8):658-666. PubMed ID: 27288720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.
    Booth C; Gilmour KC; Veys P; Gennery AR; Slatter MA; Chapel H; Heath PT; Steward CG; Smith O; O'Meara A; Kerrigan H; Mahlaoui N; Cavazzana-Calvo M; Fischer A; Moshous D; Blanche S; Pachlopnik Schmid J; Latour S; de Saint-Basile G; Albert M; Notheis G; Rieber N; Strahm B; Ritterbusch H; Lankester A; Hartwig NG; Meyts I; Plebani A; Soresina A; Finocchi A; Pignata C; Cirillo E; Bonanomi S; Peters C; Kalwak K; Pasic S; Sedlacek P; Jazbec J; Kanegane H; Nichols KE; Hanson IC; Kapoor N; Haddad E; Cowan M; Choo S; Smart J; Arkwright PD; Gaspar HB
    Blood; 2011 Jan; 117(1):53-62. PubMed ID: 20926771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral Vasculitis in X-linked Lymphoproliferative Disease Cured by Matched Unrelated Cord Blood Transplant.
    Gray PE; O'Brien TA; Wagle M; Tangye SG; Palendira U; Roscioli T; Choo S; Sutton R; Ziegler JB; Frith K
    J Clin Immunol; 2015 Oct; 35(7):604-9. PubMed ID: 26433589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-linked lymphoproliferative disease: three atypical cases.
    Nistala K; Gilmour KC; Cranston T; Davies EG; Goldblatt D; Gaspar HB; Jones AM
    Clin Exp Immunol; 2001 Oct; 126(1):126-30. PubMed ID: 11678908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives].
    Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD
    Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry.
    Gross TG; Filipovich AH; Conley ME; Pracher E; Schmiegelow K; Verdirame JD; Vowels M; Williams LL; Seemayer TA
    Bone Marrow Transplant; 1996 May; 17(5):741-4. PubMed ID: 8733691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic features of 5 Chinese patients with X-linked lymphoproliferative syndrome.
    Sun J; Ying W; Liu D; Hui X; Yu Y; Wang J; Wang X
    Scand J Immunol; 2013 Nov; 78(5):463-7. PubMed ID: 23944711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal EBV infection and variable clinical manifestations in an XLP-1 pedigree - rapid diagnosis of primary immunodeficiencies may save lives.
    Sperl D; Benesch M; Urban C; Lackner H; Sovinz P; Speicher MR; Uhrig S; Schwarzbraun T; Schwinger W; zur Stadt U; Beutel K; Janka G; Scarpatetti M; Seidel MG
    Klin Padiatr; 2012 Oct; 224(6):386-9. PubMed ID: 23143765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preimplantation genetic diagnosis of human leukocyte antigen for X-linked immunoproliferative syndrome caused by SAP mutation.
    Lukaszuk K; Kalwak K; Pukszta S; Liss J; Jakiel G; Woclawek-Potocka I; Galvao A; Wasniewski T
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():252-3. PubMed ID: 25445108
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression.
    Gilmour KC; Cranston T; Jones A; Davies EG; Goldblatt D; Thrasher A; Kinnon C; Nichols KE; Gaspar HB
    Eur J Immunol; 2000 Jun; 30(6):1691-7. PubMed ID: 10898506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.